http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106554382-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7072 |
| filingDate | 2015-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-106554382-B |
| titleOfInvention | Application in nucleoside phosphoramidite class compound and preparation method thereof and drug |
| abstract | The present invention provides the purposes of nucleoside phosphoramidite class compound and the compound as antiviral drugs shown in a kind of formula (I).The inhibitor that formula (I) compound of the invention is able to suppress the duplication of RNA virus, can be used as Hepatitis C Virus (HCV) NS5B polymerase.The compound of the present invention is while polymerizeing enzyme inhibition with NS5B, to the small toxicity of liver cell. |
| priorityDate | 2015-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 234.